# Biotech Growth Portfolio

*AI-driven catalyst selection with FDA/clinical focus*

## Investment Thesis

This Biotech Growth portfolio contains 15 positions with 12 high-conviction and 2 medium-conviction holdings.


AI Analysis: 11/15 AI BUY, 12/15 Committee BUY. Avg AI probability: 80%. Avg committee conviction: 1.

Strategy: AI-driven catalyst selection with FDA/clinical focus

Scoring integrates: AI recommendations, committee decisions, agent votes, enhanced scores, catalysts, and platform fundamentals.

## Portfolio Summary

| Metric | Value |
|--------|-------|
| Total Value | $100,000 |
| Invested | $90,000 (90.0%) |
| Cash Buffer | $10,000 (10.0%) |
| Holdings | 15 |
| Sectors | 1 |
| Avg Score | 62.3/100 |
| Avg AI Probability | 79.9% |
| Avg Committee Conviction | 1.0 |
| AI Coverage | 98% |
| Catalyst Coverage | 97% |

## Holdings

| # | Ticker | Weight | Score | AI Prob | Committee | Signal | Catalyst | Conviction |
|---|--------|--------|-------|---------|-----------|--------|----------|------------|
| 1 | **NRIX** | 6.8% | 66 | 87% | STRONG BUY | STRONG BUY | 9d | HIGH |
| 2 | **NVAX** | 6.8% | 65 | 80% | STRONG BUY | STRONG BUY | 38d | HIGH |
| 3 | **ORIC** | 6.7% | 65 | 81% | BUY | BUY | 29d | HIGH |
| 4 | **ALT** | 6.6% | 64 | 88% | BUY | BUY | 38d | HIGH |
| 5 | **DAWN** | 6.6% | 63 | 92% | STRONG BUY | STRONG BUY | 36d | HIGH |
| 6 | **CTMX** | 6.5% | 63 | 78% | STRONG BUY | STRONG BUY | 45d | HIGH |
| 7 | **GPCR** | 6.4% | 62 | 80% | STRONG BUY | STRONG BUY | 38d | HIGH |
| 8 | **REPL** | 6.4% | 62 | 81% | BUY | BUY | 24d | HIGH |
| 9 | **AMLX** | 6.4% | 62 | 74% | BUY | BUY | 43d | HIGH |
| 10 | **ERAS** | 6.4% | 62 | 86% | BUY | BUY | 59d | HIGH |
| 11 | **OCGN** | 6.3% | 60 | 83% | BUY | BUY | 45d | HIGH |
| 12 | **BCRX** | 6.2% | 60 | 77% | BUY | BUY | 35d | HIGH |
| 13 | **TWST** | 4.5% | 61 | 63% | HOLD | HOLD | 14d | MEDIUM |
| 14 | **TXG** | 4.4% | 60 | 70% | HOLD | HOLD | 23d | MEDIUM |
| 15 | **ARDX** | 3.1% | 60 | 79% | HOLD | HOLD | 31d | LOW |

## Top Holdings Analysis

### NRIX - NRIX

**Weight:** 6.8% | **Conviction:** HIGH

#### Metrics
| Metric | Value |
|--------|-------|
| Score | 66/100 |
| Market Cap | $1.9B |
| Options Flow | BULLISH |
| Squeeze Risk | HIGH |

#### AI Analysis
| Source | Value |
|--------|-------|
| AI Action | **BUY** |
| AI Confidence | MEDIUM |
| AI Probability | 86.6% |
| Committee Verdict | **STRONG BUY** |
| Committee Conviction | 1 |
| Alpha ML Probability | 60.0% |
| Trading Signal | STRONG BUY (strength: 82) |

**Agent Votes:**
- Fundamental: 68% buy prob - Positive fundamental indicators support upside. Market cap $...
- Sentiment: 76% buy prob - Positive sentiment indicators support upside...
- Technical: 55% buy prob - Mixed technical signals - recommend caution...
- Valuation: 56% buy prob - Mixed valuation signals - recommend caution. P/B: 4.0...

**AI Bull Case:** ["Platform signal indicates 63% buy consensus", "Strong sentiment and options flow favoring upside", "Earnings catalyst in 10 days with medium impact potential"]...

**AI Bear Case:** ["ML models blocked due to insufficient historical data", "Medium risk profile with 50% uncertainty", "Earnings could underperform expectations"]...

#### Score Breakdown
| Component | Value | Weight | Contribution | Source |
|-----------|-------|--------|--------------|--------|
| ✓ options_flow | 94.7 | 15% | 14.2 | options_flow_score |
| ✓ ai_probability | 86.6 | 15% | 13.0 | ai_recommendations |
| ✓ ai_committee_score | 46.5 | 20% | 9.3 | committee, verdict, agent |
| ✓ catalyst_score | 40.0 | 20% | 8.0 | catalyst_calendar |
| ✓ sentiment_score | 76.0 | 10% | 7.6 | sentiment_score |
| ✓ fundamental_score | 60.0 | 10% | 6.0 | fundamental_score |
| ✓ enhanced_score | 100.0 | 5% | 5.0 | insider, revision, surpri |
| ✓ squeeze_potential | 55.5 | 5% | 2.8 | short_squeeze_score |

#### Catalysts
- **Earnings:** 9 days
- **FDA (Phase2 Data):** 147 days - NX-5948 [HIGH]
- Earnings in 9d; Clinical catalyst in 147d

#### Bull Case
- ✓ AI recommends BUY (MEDIUM confidence)
- ✓ Committee verdict: STRONG BUY (conviction: 1)
- ✓ High AI probability (87%)
- ✓ Positive insider activity (score: +68)

#### Bear Case
- ✗ General market risk

---

### NVAX - NVAX

**Weight:** 6.8% | **Conviction:** HIGH

#### Metrics
| Metric | Value |
|--------|-------|
| Score | 65/100 |
| Market Cap | $1.3B |
| Options Flow | BULLISH |
| Squeeze Risk | EXTREME |

#### AI Analysis
| Source | Value |
|--------|-------|
| AI Action | **BUY** |
| AI Confidence | MEDIUM |
| AI Probability | 80.4% |
| Committee Verdict | **STRONG BUY** |
| Committee Conviction | 1 |
| Alpha ML Probability | 60.0% |
| Trading Signal | STRONG BUY (strength: 89) |

**Agent Votes:**
- Fundamental: 66% buy prob - Positive fundamental indicators support upside. Market cap $...
- Sentiment: 65% buy prob - Positive sentiment indicators support upside...
- Technical: 47% buy prob - Mixed technical signals - recommend caution...
- Valuation: 68% buy prob - Positive valuation indicators support upside. P/E: 4.0...

**AI Bull Case:** ["Fundamental score (70) indicates strong valuation", "Sentiment score (72) suggests positive market perception", "Options score (100) highlights potential volatility-driven gains"]...

**AI Bear Case:** ["ML models blocked due to insufficient historical data", "Medium risk profile (50/100) exposes to market volatility", "No imminent catalysts (0/3 score) limit near-term momentum"]...

#### Score Breakdown
| Component | Value | Weight | Contribution | Source |
|-----------|-------|--------|--------------|--------|
| ✓ options_flow | 100.0 | 15% | 15.0 | options_flow_score |
| ✓ ai_probability | 80.4 | 15% | 12.1 | ai_recommendations |
| ✓ ai_committee_score | 45.8 | 20% | 9.2 | committee, verdict, agent |
| ✓ sentiment_score | 72.0 | 10% | 7.2 | sentiment_score |
| ✓ fundamental_score | 70.0 | 10% | 7.0 | fundamental_score |
| ✓ catalyst_score | 30.0 | 20% | 6.0 | catalyst_calendar |
| ✓ enhanced_score | 100.0 | 5% | 5.0 | insider, revision, surpri |
| ✓ squeeze_potential | 80.0 | 5% | 4.0 | short_squeeze_score |

#### Catalysts
- **Earnings:** 38 days
- **FDA (sBLA):** 55 days - NVX-CoV2373 [HIGH]
- Regulatory catalyst in 55d

#### Bull Case
- ✓ AI recommends BUY (MEDIUM confidence)
- ✓ Committee verdict: STRONG BUY (conviction: 1)
- ✓ High AI probability (80%)
- ✓ Positive insider activity (score: +51)

#### Bear Case
- ✗ General market risk

---

### ORIC - ORIC

**Weight:** 6.7% | **Conviction:** HIGH

#### Metrics
| Metric | Value |
|--------|-------|
| Score | 65/100 |
| Market Cap | $1.2B |
| Options Flow | BULLISH |
| Squeeze Risk | EXTREME |

#### AI Analysis
| Source | Value |
|--------|-------|
| AI Action | **BUY** |
| AI Confidence | MEDIUM |
| AI Probability | 80.5% |
| Committee Verdict | **BUY** |
| Committee Conviction | 1 |
| Alpha ML Probability | 60.0% |
| Trading Signal | BUY (strength: 86) |

**Agent Votes:**
- Fundamental: 57% buy prob - Mixed fundamental signals - recommend caution. Market cap $1...
- Sentiment: 72% buy prob - Positive sentiment indicators support upside...
- Technical: 55% buy prob - Mixed technical signals - recommend caution...
- Valuation: 53% buy prob - Mixed valuation signals - recommend caution. P/B: 2.9...

**AI Bull Case:** ["Platform signal indicates 60% buy probability", "Sentiment score (72) and options activity (95) show positive momentum", "Earnings catalyst in 30 days may drive near-term volatility"]...

**AI Bear Case:** ["Technical/fundamental scores only 50 (neutral)", "No strong catalysts identified (catalyst score 0/3)", "Medium risk profile (50) with uncertain volatility environment"]...

#### Score Breakdown
| Component | Value | Weight | Contribution | Source |
|-----------|-------|--------|--------------|--------|
| ✓ options_flow | 95.9 | 15% | 14.4 | options_flow_score |
| ✓ ai_probability | 80.5 | 15% | 12.1 | ai_recommendations |
| ✓ ai_committee_score | 45.1 | 20% | 9.0 | committee, verdict, agent |
| ✓ catalyst_score | 45.0 | 20% | 9.0 | catalyst_calendar |
| ✓ sentiment_score | 72.0 | 10% | 7.2 | sentiment_score |
| ✓ fundamental_score | 50.0 | 10% | 5.0 | fundamental_score |
| ✓ enhanced_score | 100.0 | 5% | 5.0 | insider, revision, surpri |
| ✓ squeeze_potential | 70.9 | 5% | 3.5 | short_squeeze_score |

#### Catalysts
- **Earnings:** 29 days
- **FDA (Phase2 Data):** 60 days - ORIC-944 [HIGH]
- Earnings in 29d; Clinical catalyst in 60d

#### Bull Case
- ✓ AI recommends BUY (MEDIUM confidence)
- ✓ Committee verdict: BUY (conviction: 1)
- ✓ High AI probability (81%)
- ✓ Positive insider activity (score: +47)

#### Bear Case
- ✗ General market risk

---

### ALT - ALT

**Weight:** 6.6% | **Conviction:** HIGH

#### Metrics
| Metric | Value |
|--------|-------|
| Score | 64/100 |
| Market Cap | $442M |
| Options Flow | BULLISH |
| Squeeze Risk | HIGH |

#### AI Analysis
| Source | Value |
|--------|-------|
| AI Action | **BUY** |
| AI Confidence | MEDIUM |
| AI Probability | 87.6% |
| Committee Verdict | **BUY** |
| Committee Conviction | 1 |
| Alpha ML Probability | 60.0% |
| Trading Signal | BUY (strength: 86) |

**Agent Votes:**
- Fundamental: 53% buy prob - Mixed fundamental signals - recommend caution. Market cap $0...
- Sentiment: 72% buy prob - Positive sentiment indicators support upside...
- Technical: 58% buy prob - Mixed technical signals - recommend caution...
- Valuation: 64% buy prob - Mixed valuation signals - recommend caution. P/B: 2.2...

**AI Bull Case:** ["Technical and fundamental scores at 50 indicate balanced strength", "High sentiment score of 72 suggests positive market perception", "Upcoming earnings in 39 days may act as a catalyst"]...

**AI Bear Case:** ["ML models blocked due to insufficient historical data", "Medium risk rating (50) indicates moderate volatility", "Options score at 100 implies high volatility or uncertainty"]...

#### Score Breakdown
| Component | Value | Weight | Contribution | Source |
|-----------|-------|--------|--------------|--------|
| ✓ options_flow | 100.0 | 15% | 15.0 | options_flow_score |
| ✓ ai_probability | 87.6 | 15% | 13.1 | ai_recommendations |
| ✓ ai_committee_score | 45.9 | 20% | 9.2 | committee, verdict, agent |
| ✓ sentiment_score | 72.0 | 10% | 7.2 | sentiment_score |
| ✓ catalyst_score | 30.0 | 20% | 6.0 | catalyst_calendar |
| ✓ fundamental_score | 50.0 | 10% | 5.0 | fundamental_score |
| ✓ enhanced_score | 100.0 | 5% | 5.0 | insider, revision, surpri |
| ✓ squeeze_potential | 67.3 | 5% | 3.4 | short_squeeze_score |

#### Catalysts
- **Earnings:** 38 days
- **FDA (Phase2 Data):** 55 days - Pemvidutide [HIGH]
- Clinical catalyst in 55d

#### Bull Case
- ✓ AI recommends BUY (MEDIUM confidence)
- ✓ Committee verdict: BUY (conviction: 1)
- ✓ High AI probability (88%)
- ✓ Positive insider activity (score: +38)

#### Bear Case
- ✗ Small cap ($442M) volatility risk

---

### DAWN - DAWN

**Weight:** 6.6% | **Conviction:** HIGH

#### Metrics
| Metric | Value |
|--------|-------|
| Score | 63/100 |
| Market Cap | $1.0B |
| Options Flow | BULLISH |
| Squeeze Risk | HIGH |

#### AI Analysis
| Source | Value |
|--------|-------|
| AI Action | **BUY** |
| AI Confidence | MEDIUM |
| AI Probability | 91.8% |
| Committee Verdict | **STRONG BUY** |
| Committee Conviction | 1 |
| Alpha ML Probability | 60.0% |
| Trading Signal | STRONG BUY (strength: 91) |

**Agent Votes:**
- Fundamental: 63% buy prob - Mixed fundamental signals - recommend caution. Market cap $1...
- Sentiment: 77% buy prob - Positive sentiment indicators support upside...
- Technical: 56% buy prob - Mixed technical signals - recommend caution...
- Valuation: 63% buy prob - Mixed valuation signals - recommend caution. P/B: 2.3...

**AI Bull Case:** ["Strong sentiment score (82) indicates positive market perception", "Options component at 99 suggests bullish positioning", "Fundamental score of 60 shows underlying value"]...

**AI Bear Case:** ["Upcoming earnings report in 37 days may introduce volatility", "ML models lack sufficient historical data for reliable predictions", "Healthcare sector faces regulatory and pricing pressures"]...

#### Score Breakdown
| Component | Value | Weight | Contribution | Source |
|-----------|-------|--------|--------------|--------|
| ✓ options_flow | 99.7 | 15% | 15.0 | options_flow_score |
| ✓ ai_probability | 91.8 | 15% | 13.8 | ai_recommendations |
| ✓ ai_committee_score | 46.9 | 20% | 9.4 | committee, verdict, agent |
| ✓ sentiment_score | 82.0 | 10% | 8.2 | sentiment_score |
| ✓ fundamental_score | 60.0 | 10% | 6.0 | fundamental_score |
| ✓ enhanced_score | 100.0 | 5% | 5.0 | insider, revision, surpri |
| ✓ squeeze_potential | 61.8 | 5% | 3.1 | short_squeeze_score |
| ✓ catalyst_score | 15.0 | 20% | 3.0 | catalyst_calendar |

#### Catalysts
- **Earnings:** 36 days
- **FDA (PDUFA):** 131 days - DAY101 [HIGH]
- Regulatory catalyst in 131d

#### Bull Case
- ✓ AI recommends BUY (MEDIUM confidence)
- ✓ Committee verdict: STRONG BUY (conviction: 1)
- ✓ High AI probability (92%)
- ✓ Positive insider activity (score: +47)

#### Bear Case
- ✗ General market risk

---

## Sector Allocation

| Sector | Weight |
|--------|--------|
| Healthcare | 90.0% |

## Key Risks

- ⚠️ Sector concentration: Healthcare at 90%
- ⚠️ Binary regulatory/clinical risk
- ⚠️ Dilution risk
- ⚠️ General market risk

## Rebalance Triggers

- Monthly position review
- AI signal change (BUY→HOLD/SELL)
- Committee verdict change
- Position exceeds max weight
- FDA catalyst event
- Cash runway < 12 months